Key result
Echo and CMR with LGE identify apical aneurysms and fibrosis as SCD risk factors in HCM.
Why the study?
Sudden cardiac death remains the main cause of death in young patients with hypertrophic cardiomyopathy, making the identification of predictors of negative cardiovascular events essential.
Does imaging (echocardiography and MRI) improve sudden cardiac death risk assessment in patients with hypertrophic cardiomyopathy?
Does imaging (echocardiography and MRI) improve sudden cardiac death risk assessment in patients with hypertrophic cardiomyopathy?
Imaging modalities like echocardiography and MRI are essential for identifying structural and functional predictors of sudden cardiac death in patients with hypertrophic cardiomyopathy.
The current knowledge about imaging in the sudden cardiac death (SCD) risk assessment in hypertrophic cardiomyopathy (HCMP) is discussed. The overall risk of SCD in patients with HCMP is not high, but it remain the main cause of death in young patients. Implantation of cardioverter-defibrillator, surgical treatment of HCMP allow to prevent SCD and other negative cardiovascular events (heart failure and stroke) in patients with HCMP. Thus identification of predictors of negative cardiovascular events is essential in HCMP. Imaging methods (echocardiography and magnetic resonance imaging) enable to assess risk factors: left ventricular hypertrophy, left ventricular outflow tract obstruction, left atrial dimension, apical aneurysm, midventricular obstruction and extent of the late gadolinium enhancement. Role of the risk factors in SCD risk assessment in HCMP is discussed in the article.
No takes yet. Share an insight, caveat, or question.
N.D. Oryshchyn (2022) conducted a review in Hypertrophic cardiomyopathy. Imaging methods (Echocardiography, Cardiac MRI) was evaluated. Imaging methods, including echocardiography and cardiac MRI with late gadolinium enhancement, identify critical risk factors such as apical aneurysms and myocardial fibrosis for sudden cardiac death in patients with hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: